Metabolic regulation of aldose reductase activity by nitric oxide donors

被引:7
作者
Dixit, BL
Ramana, KV
Chandra, D
Jackson, EB
Srivastava, S
Bhatnagar, A
Srivastava, SK
机构
[1] Univ Texas, Med Branch, Dept Human Biol Chem, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Genet, Galveston, TX 77555 USA
[3] Univ Louisville, Div Cardiol, Jewish Cardiovasc Res Ctr, Dept Med, Louisville, KY 40202 USA
关键词
aldose reductase; nitric oxide; vascular smooth muscle cells; red blood cells;
D O I
10.1016/S0009-2797(00)00300-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation of aldose reductase (AR), a member of the aldo-keto reductase superfamily, by nitric oxide (NO) donors was examined. Incubation of human recombinant AR with S-nitrosoglutathione (GSNO) led to inactivation of the enzyme and the formation of an AR-glutathione adduct. In contrast, incubation with S-nitroso-N-acetyl penicillamine (SNAP) or N-(beta -D-glucopyranosyl)-SNAP (GlycoSNAP) led to an increase in enzyme activity which was accompanied by the direct nitrosation of the enzyme and the formation of a mixed disulfide with the NO-donor. To examine in vivo modification, red blood cells (RBC) and rat aortic vascular smooth muscle cells (VSMC) were incubated with 1 mM GSNO or SNAP. Exposure of VSMC to SNAP and GSNO for 2 h at 37 degreesC led to similar to 71% decrease in the enzyme activity with DL-glyceraldehyde as the substrate. Similarly, exposure of RBC in 5 mM glucose to NO-donors for 30 min at room temperature, followed by increasing the glucose concentration to 40 mM, resulted in > 75% decrease in the formation of; sorbitol. These investigations indicate that NO and/or ifs bioactive metabolites can regulate cellular AR, leading to either activation (by nitrosation) or inactivation (by S-thiolation). (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:573 / 581
页数:9
相关论文
共 23 条
[1]   ALDOSE REDUCTASE - CONGENIAL AND INJURIOUS PROFILES OF AN ENIGMATIC ENZYME [J].
BHATNAGAR, A ;
SRIVASTAVA, SK .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1992, 48 (02) :91-121
[2]   HUMAN PLACENTAL ALDOSE REDUCTASE - ROLE OF CYS-298 IN SUBSTRATE AND INHIBITOR BINDING [J].
BHATNAGAR, A ;
LIU, SQ ;
UENO, N ;
CHAKRABARTI, B ;
SRIVASTAVA, SK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1205 (02) :207-214
[3]   Modification of aldose reductase by S-nitrosoglutathione [J].
Chandra, A ;
Srivastava, S ;
Petrash, JM ;
Bhatnagar, A ;
Srivastava, SK .
BIOCHEMISTRY, 1997, 36 (50) :15801-15809
[4]   ALDOSE REDUCTASE - MODEL FOR A NEW PARADIGM OF ENZYMATIC PERFECTION IN DETOXIFICATION CATALYSTS [J].
GRIMSHAW, CE .
BIOCHEMISTRY, 1992, 31 (42) :10139-10145
[5]   The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene [J].
Guo, Y ;
Jones, WK ;
Xuan, YT ;
Tang, XL ;
Bao, W ;
Wu, WJ ;
Han, H ;
Laubach, VE ;
Ping, PP ;
Yang, ZQ ;
Qiu, YM ;
Bolli, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11507-11512
[6]   Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress [J].
Hsu, DKW ;
Guo, Y ;
Peifley, KA ;
Winkles, JA .
BIOCHEMICAL JOURNAL, 1997, 328 :593-598
[7]   Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-α [J].
Iwata, T ;
Sato, S ;
Jimenez, J ;
McGowan, M ;
Moroni, M ;
Dey, A ;
Ibaraki, N ;
Reddy, VN ;
Carper, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7993-8001
[8]  
JacquinBecker C, 1997, GLIA, V20, P135, DOI 10.1002/(SICI)1098-1136(199706)20:2<135::AID-GLIA5>3.0.CO
[9]  
2-8
[10]  
JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117